Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Compass Therapeutics (CMPX) Return on Sales (2024 - 2025)

Historic Return on Sales for Compass Therapeutics (CMPX) over the last 2 years, with Q1 2025 value amounting to 68.85%.

  • Compass Therapeutics' Return on Sales changed N/A to 68.85% in Q1 2025 from the same period last year, while for Mar 2025 it was 68.85%, marking a year-over-year change of. This contributed to the annual value of 66.62% for FY2024, which is N/A changed from last year.
  • Per Compass Therapeutics' latest filing, its Return on Sales stood at 68.85% for Q1 2025.
  • Compass Therapeutics' Return on Sales' 5-year high stood at 15.38% during Q2 2024, with a 5-year trough of 68.85% in Q1 2025.